Cargando…

Reply to: Utility of Serum S100B as a Marker in SLE Patients During and After the SARS-Cov-2 Pandemic

Detalles Bibliográficos
Autores principales:	Zhou, Si-Yu, Shu, Wen-Jing, Pan, Hai-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130680/ https://www.ncbi.nlm.nih.gov/pubmed/35649743 http://dx.doi.org/10.1016/j.arcmed.2022.05.005

Ejemplares similares

Utility of Serum S100B as A Marker in Systemic Lupus Erythematosus Patients During and After the SARS-CoV-2 Pandemic
por: NORIS-GARCÍA, ELENA, et al.
Publicado: (2022)

Reply to “The SARS-COV Pandemic Does Not Absolve From Solid Medical Trade”
por: Okor, Ivana, et al.
Publicado: (2021)

New-onset Evans syndrome in a patient with SLE post SARS-CoV2 mRNA vaccination
por: Ng, Timothy Y. M., et al.
Publicado: (2022)

In Reply—Repeated Testing in SARS-CoV-2 Infection
por: Shah, Aditya, et al.
Publicado: (2020)

Reply to “Intensification of an Essential Tremor by SARS-CoV-2”
por: Passaretti, Massimiliano, et al.
Publicado: (2022)

Reply to Radermacher et al. on “Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Coronavirus”
por: Renieris, Georgios, et al.
Publicado: (2021)

Reversible Focal Neuromyotonia in SLE
por: Maramattom, Boby Varkey
Publicado: (2020)

Reply to “Ample evidence suggests SARS-CoV-2 triggers polyradiculitis”
por: Esteban Molina, A., et al.
Publicado: (2022)

Reply to “Ample evidence suggests SARS-CoV-2 triggers polyradiculitis”
por: Esteban Molina, A., et al.
Publicado: (2022)

SLE presenting with catatonia in an adolescent girl
por: Grover, Sandeep, et al.
Publicado: (2013)

Hydroxychloroquine, TTP, COVID-19, and SLE
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Reply to the letter to the editor: “impact of SARS-CoV-2 vaccines on the nervous system”
por: Corrêa, Diogo Goulart, et al.
Publicado: (2022)

Reply to Letter to Editor: Is SARS-CoV-2 responsible for relapses of Parkinson’s disease?
por: Kamel, Walaa A., et al.
Publicado: (2021)

Reply to: “Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!”
por: Rabinowich, Liane, et al.
Publicado: (2022)

In Reply — Neutralization of Fecal Aerosol-Laden SARS CoV-2: Public Health Implications
por: McDermott, Carmen V., et al.
Publicado: (2021)

Author’s reply to the Letter to the Editor “The study of olfactory dysfunction in SARS-CoV-2 variants”
por: Hintschich, Constantin A., et al.
Publicado: (2022)

Utilization of SARS-COV-2 positive donors and recipients for liver transplantation in the pandemic era – An evidence-based review
por: Agrawal, Dhiraj, et al.
Publicado: (2022)

SARS-CoV-2 infection, vaccination and acquired hemophilia: Reply
por: Franchini, Massimo, et al.
Publicado: (2023)

Reply to “Indications and timing for tracheostomy in patients with SARS CoV2‐related” by Ferri et al.
por: Mattioli, Francesco, et al.
Publicado: (2020)

Neuropsychiatric complications of SLE: Raising some issues of concern
por: Pattanayak, Raman Deep, et al.
Publicado: (2011)

Severe rhabdomyolysis and SARS-CoV-2 vaccination: a reply to the letter by Dr. Josef Finsterer.: Reply to Letter to the Editor regarding our report to Dr. Finsterer.
por: Kamura, Yuya, et al.
Publicado: (2022)

Reply to “Does hand hygiene reduce SARS-CoV-2 transmission?”
por: Lai, Tracy H. T., et al.
Publicado: (2020)

Reply to: ‘No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease’
por: Ji, Dong, et al.
Publicado: (2020)

Parenteral nutrition in SARS-CoV-2 patients on non-invasive ventilation: A reply - Letter to the editor
por: Subramanian, Kritika, et al.
Publicado: (2022)

Reply: Subacute thyroiditis after anti-SARS-CoV-2 (Ad5-nCoV) vaccine()
por: Flores-Rebollar, Armando
Publicado: (2022)

Reply to: Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)
por: López-Mendez, Ivan, et al.
Publicado: (2021)

In Reply: SARS-CoV-2 Vaccination Related, Pediatric Guillain-Barre Syndrome Requires the Same Management as in Adults
por: Gunawan, Pricilla Yani
Publicado: (2023)

Reply to Letter to the Editor: “How Does SARS-CoV-2 Fragment the QRS?”
por: Halil Özdemir, İbrahim, et al.
Publicado: (2022)

Author`s Reply
por: Gu, Jun, et al.
Publicado: (2019)

Research during the SARS-CoV-2 pandemic()
por: Muñoz de Nova, José Luis, et al.
Publicado: (2021)

Emerging complexities of SARS-CoV-2 pandemic
por: Gupta, Harish
Publicado: (2021)

Immunological detection of serum antibodies in pediatric medical workers exposed to varying levels of SARS-CoV-2
por: Tu, Danna, et al.
Publicado: (2021)

A Perplexing Presentation of SLE as Adrenal Insufficiency in a Young Male
por: Bargujar, Payal, et al.
Publicado: (2021)

Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2
por: Gulmez, Ali Osman, et al.
Publicado: (2023)

Impact of COVID-19 pandemic on SLE: beyond the risk of infection
por: Horisberger, Alice, et al.
Publicado: (2020)

Author reply: comment on the drug utilization pattern in chronic obstructive pulmonary disease
por: Veettil, Sajesh Kalkandi, et al.
Publicado: (2015)

Reply to: Correspondence relating to “SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19”
por: Wang, Yijin, et al.
Publicado: (2020)

Reply to “A SARS-CoV-2 RT-PCR and Chest CT, two complementary approaches for COVID-19 diagnosis”
por: Duan, Xiaopei, et al.
Publicado: (2020)

Reply to Lassaunière: On the functional characterization of the Y453F RBD variant found in cluster 5 SARS-CoV-2
por: Bayarri-Olmos, Rafael, et al.
Publicado: (2021)

Reply to Grigoriev et al., “Sequences of SARS-CoV-2 ‘Hybrids’ with the Human Genome: Signs of Non-coding RNA?”
por: Yan, Bingyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_me5nl92rscsa6ahfic6qntgf5h